The Finnish technology group attributed the profit growth to successful cost-saving initiatives and the ongoing renewal of its operating model, which helped stabilize margins at 11.5 percent. While overall order intake softened to EUR 1.37 billion, CEO Thomas Hinnerskov noted that capital project activity in the biomaterial sector is beginning to recover from a sluggish start to the year.
Valmet Reports Growth in Sales and EBITA Amid Market Caution
Valmet Oyj posted a 6 percent rise in net sales and a comparable EBITA of EUR 152 million for the second quarter of 2026, even as the global industrial player navigated a 10 percent dip in incoming orders compared to the same period last year.
Operational efficiency remains a core focus, with the company reporting a EUR 79 million reduction in comparable selling, general, and administrative costs over the last twelve months. Following the close of the Severn acquisition on July 1, Valmet is integrating 950 new employees to bolster its flow control and automation capabilities. Despite lingering geopolitical and macroeconomic uncertainties, the company reaffirmed its full-year guidance for 2026, projecting that both net sales and comparable EBITA will meet or exceed 2025 performance levels.
Comments (0)
No comments yet. Be the first!